Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastrointest Endosc. Jun 16, 2014; 6(6): 254-259
Published online Jun 16, 2014. doi: 10.4253/wjge.v6.i6.254
Published online Jun 16, 2014. doi: 10.4253/wjge.v6.i6.254
Table 1 Demographic characteristics of patients n (%)
Characteristics | Patients (n = 20) |
Mean age in years | 47.35 ± 11.37 |
Male | 15 (75) |
Etiology | |
Viral | 9 (45) |
Alcohol | 5 (25) |
Schistosomiasis | 2 (10) |
Other | 4 (20) |
Child-Pugh class | |
A | 13 (65) |
B | 7 (35) |
Prior history of UGB | 10 (50) |
Eradication of EV | 18 (90) |
Propranolol use | 12 (60) |
Table 2 Endoscopic characteristics of patients n (%)
Characteristics | Patients (n = 20) |
GV Classification | |
GOV1 | 13 (65) |
GOV2 | 3 (15) |
IGV1 | 4 (20) |
Form of GV | |
F1 | 7 (35) |
F2 or F3 | 13 (65) |
PHG | |
Mild | 16 (80) |
Severe | 4 (20) |
RCS | 4 (20) |
Table 3 Overall results of gastric varices treatment with cyanoacrylate injection n (%)
Characteristics | Patients (n = 20) |
GV eradication | 20 (100) |
Number of sessions | |
1 | 13 (65) |
2 | 7 (35) |
Mean volume NBCM injected in mL | 1.37 ± 0.48 |
Recurrence rate | |
3 mo | 0 |
6 mo | 1 (5) |
> 2 yr | 1 (5) |
Total | 2 (10) |
Median follow-up in months (range) | 31 (6-40) |
Late bleeding rate | 1 (5) |
Minor adverse events1 | 3 (15) |
Major adverse events | 0 |
Overall mortality rate | 0 |
- Citation: Franco MC, Gomes GF, Nakao FS, de Paulo GA, Ferrari Jr AP, Libera Jr ED. Efficacy and safety of endoscopic prophylactic treatment with undiluted cyanoacrylate for gastric varices. World J Gastrointest Endosc 2014; 6(6): 254-259
- URL: https://www.wjgnet.com/1948-5190/full/v6/i6/254.htm
- DOI: https://dx.doi.org/10.4253/wjge.v6.i6.254